Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: A dose-response meta-analysis of 21 cohort studies

American Journal of Clinical Nutrition

Volumn 103, Issue 2, 2016, Pages 330-340

  Zhang, Yu ^a   Chen, Jingnan ^a   Qiu, Jieni ^b   Li, Yingjun ^b   Wang, Jianbing ^b   Jiao, Jingjing ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alzheimer disease; Cognitive impairment; Dementia; Fish; Polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; EDIBLE OIL;

ADVERSE OUTCOME; ALZHEIMER DISEASE; ARTICLE; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CORONARY RISK; DEMENTIA; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FISH; FOLLOW UP; HUMAN; LOW RISK POPULATION; MILD COGNITIVE IMPAIRMENT; OUTCOME ASSESSMENT; PARKINSON DISEASE; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; ADVERSE EFFECTS; ANIMAL; COGNITION DISORDERS; DIET; DIETARY SUPPLEMENT; META ANALYSIS; PATHOPHYSIOLOGY; SEA FOOD; SEVERITY OF ILLNESS INDEX;

ALZHEIMER DISEASE; ANIMALS; COGNITION DISORDERS; DEMENTIA; DIET; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISHES; HUMANS; MILD COGNITIVE IMPAIRMENT; RISK FACTORS; SEAFOOD; SEVERITY OF ILLNESS INDEX;

EID: 84956958350     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.124081     Document Type: Article

References (77)

1. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, Anderson W, Dhansay MA, Phillips A, et al. Grand challenges in global mental health. Nature 2011;475:27-30.
2. Karr JE, Alexander JE, Winningham RG. Omega-3 polyunsaturated fatty acids and cognition throughout the lifespan: a review. Nutr Neurosci 2011;14:216-25.
3. Féart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, Scarmeas N, Barberger-Gateau P. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009;302:638-48.
4. Valls-Pedret C, Sala-Vila A, Serra-Mir M, Corella D, de la Torre R, Martínez-González MA, Martínez-Lapiscina EH, Fitó M, Pérez-Heras A, Salas-Salvadó J, et al. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern Med 2015;175:1094-103.
5. Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: finDings from animal and clinical studies. Neuropharmacology 2013;64:550-65.
6. Huang TL. Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. J Alzheimers Dis 2010;21:673-90.
7. Joffre C, Nadjar A, LebbaDi M, Calon F, Laye S. n-3 LCPUFA improves cognition: the young, the old and the sick. Prostaglandins Leukot Essent Fatty Acids 2014;91:1-20.
8. Albanese E, Dangour AD, Uauy R, Acosta D, Guerra M, Guerra SS, Huang Y, Jacob KS, de Rodriguez JL, Noriega LH, et al. Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study. Am J Clin Nutr 2009;90:392-400.
9. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alpérovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 2007;69:1921-30.
10. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the Rotterdam study. Ann Neurol 1997;42:776-82.
11. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003;60:940-6.
12. Devore EE, Grodstein F, van Rooij FJA, Hofman A, Rosner B, Stampfer MJ, Witteman JC, Breteler MM. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk. Am J Clin Nutr 2009;90:170-6.
13. Huang TL, ZanDi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke GL, Carlson MC. Benefits of fatty fish on dementia risk are stronger for those without APOE e4. Neurology 2005;65:1409-14.
14. Lin P-Y, Chiu C-C, Huang S-Y, Su K-P. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry 2012;73:1245-54.
15. Mazereeuw G, Lanctôt KL, Chau SA, Swardfager W, Herrmann N. Effects of v-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging 2012;33:1482.e17-29.
16. Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012;6:CD005379.
17. Wu S, Ding Y, Wu F, Li R, Hou J, Mao P. Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis. Neurosci Biobehav Rev 2015;48:1-9.
18. Bishop NA, Lu T, Yankner BA. Neural mechanisms of ageing and cognitive decline. Nature 2010;464:529-35.
19. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
20. Wells GA, Shea G, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [Internet]. Ottawa (Canada): The Ottawa Hospital Research Institute. [cited 2013 Oct 26]. The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.as.p.
21. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280: 1690-1.
22. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006;6:40-57.
23. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66-73.
24. Chen H, Zhang SM, Hernán MA, Willett WC, Ascherio A. Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol 2003; 157:1007-14.
25. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 2004; 109:2705-11.
26. Global Organization for EPA and DHA Omega-3s (GOED). Global recommendations for EPA and DHA intake [Internet]. [cited 2014 Apr 16]. GOED, Salt Lake City, UT, USA. Available from: http://www.goedomega3.com/index.php/files/download/304.
27. Jackson D, White IR, Thompson SG. ExtenDing DerSimonian and Laird's methodology to perform multivariate random effects metaanalyses. Stat Med 2010;29:1282-97.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
29. González S, Huerta JM, Fernández S, Patterson A M, Lasheras C. The relationship between dietary lipids and cognitive performance in an elderly population. Int J Food Sci Nutr 2010;61:217-25.
30. Kesse-Guyot E, Péneau S, Ferry M, Jeandel C, Hercberg S, Galan P, SU.VI.MAX 2 Research Group. Thirteen-year prospective study between fish consumption, long-chain n-3 fatty acids intakes and cognitive function. J Nutr Health Aging 2011;15:115-20.
31. Nurk E, Drevon CA, Refsum H, Solvoll K, Vollset SE, Nygård O, Nygaard HA, Engedal K, Tell GS, Smith AD. Cognitive performance among the elderly and dietary fish intake: the Hordaland Health Study. Am J Clin Nutr 2007;86:1470-8.
32. Roberts RO, Geda YE, Cerhan JR. Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment. Dement Geriatr Cogn Disord 2010;29:413-23.
33. Ammann EM, Pottala JV, Harris WS, Espeland MA, Wallace R, Denburg NL, Carnahan RM, Robinson JG. v-3 fatty acids and domainspecific cognitive aging: secondary analyses of data from WHISCA. Neurology 2013;81:1484-91.
34. Beydoun MA, Kaufman JS, Sloane PD, Heiss G, Ibrahim J. n-3 Fatty acids, hypertension and risk of cognitive decline among older adults in the Atherosclerosis Risk in Communities (ARIC) study. Public Health Nutr 2008;11:17-29.
35. Cherubini A, Andres-Lacueva C, Martin A, Lauretani F, Iorio AD, Bartali B, Corsi A, Bandinelli S, Mattson MP, Ferrucci L. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2007;62:1120-6.
36. Okereke OI, Rosner BA, Kim DH. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol 2012; 72:124-34.
37. Solfrizzi V, Panza F, Torres F, Mastroianni F, Del Parigi A, Venezia A, Capurso A. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 1999;52:1563-9.
38. Velho S, Marques-Vidal P, Baptista F, Camilo ME. Dietary intake adequacy and cognitive function in free-living active elderly: a crosssectional and short-term prospective study. Clin Nutr 2008;27:77-86.
39. Wang W, Shinto L, Connor WE, Quinn JF. Nutritional biomarkers in Alzheimer's disease: the association between carotenoids, n-3 fatty acids, and dementia severity. J Alzheimers Dis 2008;13:31-8.
40. Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, Fox HC. n-3 Fatty acid erythrocyte membrane content, APOE e4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 2008;87:449-54.
41. Zhang J, Hebert JR, Muldoon MF. Dietary fat intake is associated with psychosocial and cognitive functioning of school-aged children in the United States. J Nutr 2005;135:1967-73.
42. Gao Q, Niti M, Feng L, Yap KB, Ng T-P. Omega-3 polyunsaturated fatty acid supplements and cognitive decline: Singapore Longitudinal Aging Studies. J Nutr Health Aging 2011;15:32-5.
43. Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 2003;5:315-22.
44. Beydoun MA, Kaufman JS, Satia JA, Rosamond W, Folsom AR. Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2007; 85:1103-11.
45. de Lau LML, Bornebroek M, Witteman JCM, Hofman A, Koudstaal PJ, Breteler MMB. Dietary fatty acids and the risk of Parkinson disease: the Rotterdam Study. Neurology 2005;64:2040-5.
46. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM. Diet and risk of dementia: does fat matter? The Rotterdam Study. Neurology 2002;59:1915-21.
47. Eskelinen MH, Ngandu T, Helkala E-L, Tuomilehto J, Nissinen A, Soininen H, Kivipelto M. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry 2008;23:741-7.
48. Heude B, Ducimetière P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes-the EVA Study. Am J Clin Nutr 2003;77:803-8.
49. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997;145:33-41.
50. Kim M, Nam JH, Oh DH, Park Y. Erythrocyte a-linolenic acid is associated with the risk for mild dementia in Korean elderly. Nutr Res 2010;30:756-61.
51. Kröger E, Verreault R, Carmichael P-H, Lindsay J, Julien P, Dewailly E, Ayotte P, Laurin D. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging. Am J Clin Nutr 2009;90:184-92.
52. Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M. Fat intake at midlife and risk of dementia and Alzheimer's disease: a populationbased study. Dement Geriatr Cogn Disord 2006;22:99-107.
53. Lopez LB, Kritz-Silverstein D, Barrett-Connor E. High dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the Rancho Bernardo Study. J Nutr Health Aging 2011;15:25-31.
54. Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, et al. Dietary fat intake and risk of Parkinson's disease: a case-control study in Japan. J Neurol Sci 2010;288:117-22.
55. Roberts RO, Cerhan JR, Geda YE, Knopman DS, Cha RH, Christianson TJ, Pankratz VS, Ivnik RJ, O'Connor HM, Petersen RC. Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. J Alzheimers Dis 2010;21:853-65.
56. Samieri C, Féart C, Letenneur L, Dartigues JF, Pérès K, Auriacombe S, Peuchant E, Delcourt C, Barberger-Gateau P. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr 2008;88:714-21.
57. Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Del Parigi A, Capurso SA, Argentieri G, Capurso A, Panza F. Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp Gerontol 2006;41:619-27.
58. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006;63:1545-50.
59. Jiao J, Li Q, Chu J, Zeng W, Yang M, Zhu S. Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2014;100:1422-36.
60. Mohajeri MH, Troesch B, Weber P. Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia. Nutrition 2015;31:261-75.
61. Bateman RJ, Xiong CJ, Benzinger TLS, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
62. Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 2011;31:321-51.
63. Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet 2013;381:2016-23.
64. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr., Weiner M, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010;304:1903-11.
65. Bégin ME, Plourde M, Pifferi F, Cunnane SC. What is the link between docosahexaenoic acid, cognitive impairment, and Alzheimer's disease in the elderly? In: Montmayeur JP, le Coutre J, editors. Fat detection: taste, texture, and post ingestive effects. Frontiers in Neuroscience. Boca Raton (FL): CRC Press/Taylor & Francis; 2010.
66. Amboni M, Tessitore A, Esposito F, Santangelo G, Picillo M, Vitale C, Giordano A, Erro R, de Micco R, Corbo D, et al. Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease. J Neurol 2015;262:425-34.
67. Pedersen KF, Larsen JP, Tysnes O-B, Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 2013;70:580-6.
68. Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease. The TEAM-AD VA Cooperative Randomized Trial. JAMA 2014;311: 33-44.
69. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M,Woodbury P, Growdon J, Cotman CW, Pfeiffer E, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997;336:1216-22.
70. Gumpricht E, Rockway S. Can v-3 fatty acids and tocotrienol-rich vitamin E reduce symptoms of neurodevelopmental disorders? Nutrition 2014;30:733-8.
71. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352:2379-88.
72. Kang JH, Cook N, Manson J, Buring JE, Grodstein F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006;166:2462-8.
73. Barberger-Gateau P, Samieri C, Féart C, Plourde M. Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res 2011;8:479-91.
74. Deary IJ, Whitman MC, Pattie A, Starr JM, Hayward C, Wright AF, Carothers A, Whalley LJ. Cognitive change and the APOE e4 allele. Nature 2002;418:932.
75. Raber J, Wong D, Yu G-Q, Buttini M, Mahley RW, Pitas RE, Mucke L. Apolipoprotein E and cognitive performance. Nature 2000;404:352-4.
76. Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh EL, Silver DL. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014; 509:503-6.
77. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.